about
High-Risk Cardiovascular Patients: Clinical Features, Comorbidities, and Interconnecting MechanismsHow do we approach thrombocytopenia in critically ill patients?Haemolytic uraemic syndrome.Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of Escherichia coli sepsis.STEC-HUS, atypical HUS and TTP are all diseases of complement activation.Platelets in pulmonary vascular physiology and pathology.Minor Role of Plasminogen in Complement Activation on Cell Surfaces.Platelets and infections in the resource-limited countries with a focus on malaria and viral haemorrhagic fevers.Neutrophil-dependent acute lung injury. Requirement for P-selectin (GMP-140)Interactions between coagulation and complement--their role in inflammationPlatelet activation leads to activation and propagation of the complement system.Deficiency of decay-accelerating factor and complement receptor 1-related gene/protein y on murine platelets leads to complement-dependent clearance by the macrophage phagocytic receptor CRIgPlatelet mediated complement activationIdentification of a novel mode of complement activation on stimulated platelets mediated by properdin and C3(H2O).Mechanisms of complement activation, C4d deposition, and their contribution to the pathogenesis of antibody-mediated rejection.CD62 and endothelial cell-leukocyte adhesion molecule 1 (ELAM-1) recognize the same carbohydrate ligand, sialyl-Lewis x.Human monocyte-endothelial cell interaction in vitro.Modulatory Role of Surface Coating of Superparamagnetic Iron Oxide Nanoworms in Complement Opsonization and Leukocyte Uptake.Cardiac dysfunction caused by purified human C3a anaphylatoxin.Platelets and the complement cascade in atherosclerosis.Proteinases, Their Extracellular Targets, and Inflammatory Signaling.Cross-talk between α7 nAChR-mediated cholinergic pathway and acylation stimulating protein signaling in 3T3-L1 adipocytes: role of NFκB and STAT3.Storage of single donor platelet concentrates: paired comparison of storage as single or double concentrates.Complement activation by recombinant adenoviruses.In vitro function of platelet concentrates prepared after filtration of whole blood or buffy coat pools.Microvesicle Involvement in Shiga Toxin-Associated Infection.MASP-1 of the complement system enhances clot formation in a microvascular whole blood flow model.Platelets orchestrate remote tissue damage after mesenteric ischemia-reperfusion.
P2860
Q26774658-8E3D93AA-AD69-4BAD-85B3-D9D5D10CE73DQ30240053-2BFE8E9C-3C14-4114-BB09-7DEA12BDE6E5Q30244707-2B2A587B-94A6-48A8-B47F-322453EB2A38Q33389544-241C0988-4EB4-4431-80C0-A04F52B3A4BFQ33403359-6191EB8C-5DEB-433B-9EF5-D210ED98937AQ33404240-8A029DDF-D3BB-4618-B1A6-075279CB9206Q33428157-8E2CE29C-392C-4A03-9CF7-AFB27489111CQ33440142-C9BED59A-DD88-428E-9E22-74D87085955CQ35607537-06C6735F-5131-4381-B466-4ABFA7133EC6Q36022738-F82101F0-2318-4AF1-9DA6-10E4E34101E5Q36403387-B7B05075-C4B1-4010-8430-9EC45855ED24Q36835163-96C56142-7EBB-481E-A39D-C5F6653A0134Q37088046-52D3F84F-A6A8-47B0-AFE5-6FDE613801E0Q37200463-7CA9AC60-1EF1-492D-BDDF-DBCCEFD5EE11Q37441972-D43686EC-2AFE-4EA6-9DC2-DF67D29C9CB0Q37548676-F32C0512-21C3-4827-9D80-349CDBBF8BF4Q37557808-19FFB004-B5E1-42CB-A88B-AA3592D03C94Q37577978-344F7965-247B-4DD7-9F34-DF6A85737CCBQ37677178-C6A18704-52E2-4CA9-8CC4-5BC0D8853EECQ38382518-5AC196EB-C369-4801-919B-658952FB66B0Q38966192-67096F54-3BC5-42E3-A27A-CFD1EAD31F8BQ42827182-D960CF9B-03D1-469B-8066-B71406D5C7BFQ43825478-F6CAA9F8-CC9D-45A7-BEE8-7D896E6AC82AQ43861771-E16EDCAF-B4FE-4F77-A3B4-D42BF49AC846Q46401345-37B15F5D-3D9B-493F-AD1B-93F5B3716C05Q47127903-D2F331C5-9207-44F0-B186-9E1400BFE9A9Q48259032-55C9623B-17FB-4158-AC1D-15497D3B6BFDQ53188141-84EFA60C-B34C-43B7-8316-60D136408A00
P2860
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年学术文章
@wuu
1983年学术文章
@zh-cn
1983年学术文章
@zh-hans
1983年学术文章
@zh-my
1983年学术文章
@zh-sg
1983年學術文章
@yue
1983年學術文章
@zh
1983年學術文章
@zh-hant
name
Human platelet activation by C3a and C3a des-arg.
@ast
Human platelet activation by C3a and C3a des-arg.
@en
type
label
Human platelet activation by C3a and C3a des-arg.
@ast
Human platelet activation by C3a and C3a des-arg.
@en
prefLabel
Human platelet activation by C3a and C3a des-arg.
@ast
Human platelet activation by C3a and C3a des-arg.
@en
P2860
P356
P1476
Human platelet activation by C3a and C3a des-arg.
@en
P2093
M J Polley
R L Nachman
P2860
P304
P356
10.1084/JEM.158.2.603
P407
P577
1983-08-01T00:00:00Z